Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other Accumulated Expenses (2022 - 2025)

Sanara MedTech (SMTI) has disclosed Other Accumulated Expenses for 4 consecutive years, with $228001.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses fell 88.04% year-over-year to $228001.0, compared with a TTM value of $228001.0 through Sep 2025, down 88.04%, and an annual FY2023 reading of $1.1 million, down 5.41% over the prior year.
  • Other Accumulated Expenses was $228001.0 for Q3 2025 at Sanara MedTech, up from $39659.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.9 million in Q3 2024 and bottomed at $39659.0 in Q2 2025.
  • Average Other Accumulated Expenses over 4 years is $888853.3, with a median of $989744.0 recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses soared 90.66% in 2024, then tumbled 96.35% in 2025.
  • Year by year, Other Accumulated Expenses stood at $1.2 million in 2022, then dropped by 5.41% to $1.1 million in 2023, then skyrocketed by 73.32% to $1.9 million in 2024, then plummeted by 88.04% to $228001.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for SMTI at $228001.0 in Q3 2025, $39659.0 in Q2 2025, and $1.9 million in Q3 2024.